Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-03-14Clinical Trial Update: The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration
This clinical trial update examines how genetic polymorphisms in ABCB1, CYP3A4, CYP3A5, POR and other factors influence tacrolimus blood con…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Sirolimus Conversions in African-American Renal Transplant Recipients [NA]
This clinical trial update reports results from a completed study evaluating sirolimus conversions in African-American kidney transplant rec…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients [Phase 4]
A Phase 4 clinical trial comparing extended-release tacrolimus plus sirolimus to extended-release tacrolimus plus mycophenolate mofetil in k…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Biomarkers of Aging as Predictors of Kidney Transplant Function
A completed clinical trial evaluating aging-related biomarkers as predictors of kidney transplant function, including delayed graft function…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Desensitization in Kidney Transplantation [Phase 4]
Phase 4 trial update on desensitization to enable kidney transplantation in HLA-sensitized patients, with results posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Left Ventricular Diastolic Dysfunction in Kidney Recipients
A completed clinical trial update examining left ventricular diastolic dysfunction in kidney transplant recipients, sponsored by Severance H…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation [Phase 3]
Phase 3 study comparing FK506MR with Prograf (tacrolimus) in kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients [Phase 2]
Phase 2 study evaluating the efficacy and safety of Alefacept in de novo kidney transplant recipients; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients [Phase 3]
Phase 3 clinical trial update on treating autonomous hyperparathyroidism in post-renal transplant recipients; results completed with posted …
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients [Phase 4]
This Phase 4 randomized trial update reports results from induction therapies in high immunological risk kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax) [Phase 4]
Phase 4 trial update evaluating immune response in pediatric kidney transplant recipients treated with daclizumab (Zenapax); results were po…
-
CLINICAL_TRIALS research · 2016-01-01Clinical Trial Update: Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients [NA]
A clinical trial is studying edaravone for ischemia-reperfusion injury in kidney transplantation patients. The current trial status is unkno…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients [Phase 3]
Phase 3 randomized trial comparing Tacrolimus (Prograf) with Prograf-XL in de novo kidney transplant recipients; study completed.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients [Phase 3]
Phase 3 bioequivalence study comparing ganciclovir from valganciclovir syrup to Valcyte 450 mg tablet (900 mg total) in kidney transplant re…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant [Phase 4]
Clinical trial update on Phase 4 kidney transplant patients assessing how quadruple immunosuppression affects peripheral blood lymphocytes a…
-
FDA approval · 2015-12-15FDA Approved: TACROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for tacrolimus submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2015-11-24Clinical Trial Update: Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation [Phase 3]
An ongoing Phase 3 clinical trial evaluating hydrogen-rich Celsior solution as a preservation method in aging donation-after-brain-death liv…
-
CLINICAL_TRIALS research · 2015-11-20Clinical Trial Update: Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients? [NA]
A clinical trial is evaluating whether technology apps can improve medication adherence in adolescents who have received kidney transplants.…
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Teva Pharmaceuticals USA, Inc., updating the drug's label…
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic version of mycophenolate mofetil from Hikma Pharmaceuticals USA Inc. The drug is u…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. [Phase 3]
A Phase 3 trial comparing two dosing regimens of CellCept (mycophenolate mofetil) in kidney transplant patients has completed and results we…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Rituximab for Prevention of Rejection After Renal Transplantation [Phase 2, Phase 3]
Rituximab evaluated to prevent rejection after kidney transplantation in Phase 2 and Phase 3 trials; the studies are reported as completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants [Phase 3]
Phase 3 trial (CLEAR Study) evaluating CellCept (mycophenolate mofetil) in kidney transplant recipients has completed.
-
FDA label_change · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA supplemental application for mycophenolate mofetil filed by Hikma Pharmaceuticals USA Inc. to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
This clinical-trial update analyzes Foxp3 and Vimentin expression in renal transplant recipients to study immune regulation and tissue remod…